[1]
Putri, A., Rinaldi, I., Louisa, M. and Koesnoe, S. 2020. The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. Acta Medica Indonesiana. 51, 4 (Feb. 2020), 348.